Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A rare form of retinal dystrophy, seen mostly in Northern Sweden, presenting in early childhood with night blindness and progressive maculopathy with a decrease in visual acuity, eventually leading to blindness by adulthood. Retinal degeneration, without obvious bone spicule formation, accompanied by affected visual fields and the typical presence of retinitis punctata albescens in the posterior pole are also noted.
Features include: Nyctalopia, Macular degeneration, Abnormal electroretinogram, and Retinal dystrophy.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Eyes | 2 | Macular degeneration, Retinal dystrophy |
RLBP1 function has not been fully characterized.
Bothnia retinal dystrophy is associated with mutations in the RLBP1 gene on chromosome 15.
Genetic testing for RLBP1 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for Bothnia retinal dystrophy has been reported in the published literature.
Estimated prevalence: Unknown (Unknown prevalence).
No clinical trials have been registered for Bothnia retinal dystrophy.
3 publications have been identified in PubMed for Bothnia retinal dystrophy. Research spans Diagnostic / Biomarker (33%), Basic Science / Preclinical (33%), and Gene Therapy / Novel Therapeutics (33%).
Fehilly JD (2025). [PMID: 40552921](https://pubmed.ncbi.nlm.nih.gov/40552921/). *FASEB J*. [Diagnostic / Biomarker]
De Geer K (2025). [PMID: 39643591](https://pubmed.ncbi.nlm.nih.gov/39643591/). *Acta Ophthalmol*. [Basic Science / Preclinical]
Damodar K (2024). [PMID: 39385467](https://pubmed.ncbi.nlm.nih.gov/39385467/). *Mol Ther*. [Gene Therapy / Novel Therapeutics]
Data assembled from 6 of 12 sources · Last updated Sep 19, 2026, 1:53 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about Bothnia retinal dystrophy